We are thrilled to have Markus Weber, the CEO, and Justus Felix Wehmer, the CFO of Carl Zeiss Meditech AG, here with us today. They will be presenting the Financials: H1-2021/22 of the company.
Â
Markus Weber brings a wealth of experience to Carl Zeiss Meditech AG. Before joining the company, he served as the CEO of another leading medical technology firm for several years. Under his leadership, the company experienced significant growth and expanded its global reach.
Â
Justus Felix Wehmer has a strong background in finance and accounting. He has held various senior positions in finance, including at a major international bank. At Carl Zeiss Meditech AG, he has played a critical role in the company’s financial strategy and planning.
Â
Markus and Justus will share with us the Financials: H1-2021/22 of Carl Zeiss Meditech AG, a leading player in the medical technology industry. We can expect to hear about the company’s performance over the last six months, its financial position, and its plans for the future. With these two experts at the helm, we will surely gain valuable insights into the company’s success and future prospects.
The Medical Technology activities of ZEISS are bundled under the umbrella of the MDAX- and TecDAX-listed company Carl Zeiss Meditec AG.Â
Â
With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world in major markets. The company can also exploit the Carl Zeiss group`s powerful global distribution network.
Â
Two Pillars of Business & Markets:
The main activities of Carl Zeiss Meditec AG are located in the field of Ophthalmology and Microsurgery
In Ophthalmology, the Company offers mainly products and solutions for the diagnosis and treatment of eye diseases, as well as systems and consumables for cataract, retinal and refractive surgery.Â
In Microsurgery the Carl Zeiss Meditec Group provides visualization solutions for minimally invasive surgical treatments.
Â
Markets:
The Carl Zeiss Meditec Group has operations all over the world.Â
With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world’s most important markets.
Â
Milestones & Innovations:
Research and development plays an important role within the Carl Zeiss Meditec Group.Â
Our objective is to enable our customers and physicians to continuously improve treatment results through improvements in efficiency and innovative new products
Dr. Markus Weber
CEO | Carl Zeiss Meditec AG
Justus Felix Wehmer
CFO | Carl Zeiss Meditec AG
This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/
Austria:
Estonia:
Germany:
seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG
Â
Unlock the insights of top publicly listed companies with seat11a.com
Elevate your understanding with powerful Elevator Pitches, Deep-Dive Presentations, and in-depth Financial Analysis
May 16, 2022
04:26 
Reviews for Carl Zeiss Meditec AG | Financials: H1-2021/22 | Markus Weber, CEO and Justus Felix Wehmer, CFO